SKIN SQUAMOUS CELL CARCINOMA
Clinical trials for SKIN SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SKIN SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SKIN SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Tailor-Made cancer vaccine shows promise in advanced tumors
Disease control Recruiting nowThis study tests a personalized vaccine made from a patient's own tumor proteins, combined with the immunotherapy drug pembrolizumab, for people with advanced solid tumors. The goal is to see if this combination is safe and helps the immune system fight cancer more effectively. A…
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Immune cells injected into tumors show promise for skin cancer
Disease control Recruiting nowThis early-phase trial tests whether injecting special immune cells called natural killer (NK) cells directly into skin cancer tumors is safe and can help kill the cancer. It compares two types of NK cells—standard ones and a more powerful type from donors exposed to a common vir…
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: EARLY_PHASE1 • Sponsor: Kirsten Johnson • Aim: Disease control
Last updated May 11, 2026 20:40 UTC
-
Can a simple cream take the sting out of cancer mapping?
Symptom relief Recruiting nowThis study tests whether EMLA numbing cream can reduce pain from Technetium 99 injections used in lymphoscintigraphy, a standard mapping procedure for skin cancers like melanoma. About 100 adults with skin cancer will receive either EMLA cream or a placebo before the injection. R…
Matched conditions: SKIN SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Ohio State University Comprehensive Cancer Center • Aim: Symptom relief
Last updated May 04, 2026 16:31 UTC